查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829846

2025年全球植入式神经刺激设备市场报告

Implantable Neurostimulation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，植入式神经刺激设备市场快速扩张，市场规模从2024年的50.2亿美元成长至2025年的56.2亿美元，复合年增长率为11.8%。预测期内的增长归因于非药物治疗需求的不断增长、微创手术需求的不断增长、老年人口的增长、各种精神疾病患病率的不断上升以及慢性病患病率的不断上升。

预计未来几年植入式神经刺激设备市场将快速成长，到2029年将达到88.6亿美元，复合年增长率为12.1%。预测期内的成长归因于神经系统疾病盛行率的上升、文明病盛行率的上升、认知度的提高、脊髓损伤发生率的上升以及医疗保健支出的增加。预测期内的主要趋势包括感测和神经刺激技术的不断进步、技术先进的产品、闭合迴路系统的整合以及无线技术的整合。

植入式神经刺激设备是医疗设备，旨在向神经系统的特定部位传递电刺激，以治疗各种神经和心理疾病。这些装置透过手术植入体内，调节神经活动，为单靠药物无法充分治疗的疾病提供了一种先进的治疗方法，从而改善患者的生活品质。

植入式神经刺激设备的主要类型包括脊髓刺激 (SCS)、胃电刺激 (GES)、深部脑部刺激 (DBS)、荐椎神经刺激(SNS) 和迷走神经刺激 (VNS)。脊髓刺激 (SCS) 疗法利用弱电流阻断疼痛讯号到达大脑，有效治疗慢性疼痛。这些装置用于治疗疼痛、帕金森氏症、尿失禁、大便失禁、癫痫和胃轻瘫。它们的终端使用者多种多样，包括医院、诊所和门诊手术中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供植入式神经刺激设备的市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的植入式神经刺激设备神经刺激设备市场、市场趋势和机会，以及神经刺激设备在神经刺激设备行业取得成功所需的数据。本植入式神经刺激设备市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长12.1%，较先前预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自奥地利和丹麦等主要地区的定向导线阵列和可充电电源征收关税直接影响美国，从而导致运动障碍的治疗选择减少，神经调节疗法的成本上升。此外，这种影响可能透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，更为广泛地显现。

神经系统疾病的日益普及预计将推动植入式神经刺激设备市场的未来成长。神经系统疾病会影响神经系统的结构和功能，导致各种症状，包括瘫痪、癫痫和认知障碍。高血压、发育异常以及创伤和损伤等因素会导致这些疾病的发生率上升。当其他治疗方法无效或不足时，植入式神经刺激设备可用于调节神经活动并缓解症状。例如，美国非营利组织阿兹海默症症协会报告称，到 2024 年，约有 690 万 65 岁及以上的美国将患上阿兹海默症，其中 73% 的 75 岁及以上人群将患有该病。预计到 2050 年，这一数字将增至 1,270 万。因此，神经系统疾病的日益普及预计将推动植入式神经刺激设备市场的成长。

植入式神经刺激设备市场的主要参与者正在开发先进技术，例如脊髓刺激 (SCS) 系统，以治疗慢性疼痛。 SCS 系统是医疗设备，它使用电脉衝调节脊髓神经活动，在其他治疗方法无效时缓解疼痛并改善患者的生活品质。例如，2022 年 12 月，美国医疗设备製造商雅培 (Abbott) 的 Eterna 脊髓刺激 (SCS) 系统获得了 FDA核准。 Eterna SCS 是市面上最小的可充电植入式脊髓刺激设备，旨在最大限度地提高舒适度。它采用雅培的 BurstDR 刺激技术，该技术可复製自然的脑放电模式以增强疼痛缓解，与传统的刺痛刺激相比，87% 的患者更喜欢它。 Eterna 的 Xtend 能量技术每年只需充电五次，其 TotalScan 技术使其与全身 MRI 扫描相容。它还可以适应未来的发展而无需更换。与雅培行动应用程式的整合使用户可以在 iPhone 装置上即时追踪电池寿命和充电状态。

2023年9月，总部位于英国的神经调节疗法提供者Amber Therapeutics收购了BioInduction，收购金额未揭露。此次收购为Amber提供了宝贵的硬体、专业知识和製造经验，加速了Amber-UI的开发和商业化。 BioInduction是一家总部位于英国的製造商，专注于植入式神经刺激设备。

植入式神经刺激设备市场涵盖响应式神经刺激系统、週边神经刺激系统、脑脊髓液分流系统和电疗设备的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式神经刺激设备：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球植入式神经刺激设备市场：成长率分析
  • 全球植入式神经刺激设备市场表现：规模与成长，2019-2024
  • 全球植入式神经刺激设备市场预测：规模与成长，2024-2029，2034
  • 全球植入式神经刺激设备：总目标市场（TAM）

第六章 市场细分

  • 全球植入式神经刺激设备市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 脊髓刺激（SCS）
  • 胃电刺激（GES）
  • 深部脑部刺激（DBS）
  • 荐椎神经刺激（SNS）
  • 迷走神经刺激（VNS）
  • 其他类型
  • 全球植入式神经刺激设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 疼痛管理
  • 帕金森氏症
  • 尿失禁和大便失禁
  • 癫痫
  • 胃轻瘫
  • 其他用途
  • 全球植入式神经刺激设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 门诊手术中心
  • 全球植入式神经刺激设备市场：脊髓刺激（SCS）细分、类型、表现及预测，2019-2024年、2024-2029年、2034年
  • 可充电 SCS 设备
  • 不可充电的SCS设备
  • 全球植入式神经刺激设备市场：按胃电刺激 (GES) 细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式胃刺激装置
  • 可调式胃刺激器
  • 全球植入式神经刺激设备市场：按深部脑部刺激 (DBS) 细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗运动障碍的DBS设备
  • 用于治疗精神疾病的DBS设备
  • 全球植入式神经刺激设备市场：按骶荐椎神经刺激(SNS) 细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 尿失禁治疗仪
  • 用于治疗大便失禁的SNS装置
  • 全球植入式神经刺激设备市场：迷走神经刺激 (VNS) 细分、类型、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 用于治疗癫痫的迷走神经刺激装置
  • 治疗忧郁症的迷走神经刺激装置
  • 全球植入式神经刺激设备市场：按类型、其他、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 週边神经刺激（PNS）
  • 皮层刺激器
  • 新的神经刺激技术

第七章 区域和国家分析

  • 全球植入式神经刺激设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式神经刺激设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 植入式神经刺激设备市场：竞争格局
  • 植入式神经刺激设备市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • LivaNova PLC
  • Nevro Corp.
  • Axonics Inc.
  • NeuroPace Inc.
  • Bioness Inc.
  • Saluda Medical Pty Ltd.
  • SceneRay Co. Ltd.
  • NeuroMetrix Inc.
  • CURE Epilepsy
  • Synapse Biomedical Inc.
  • NeuroSigma Inc.
  • Nuvectra Corporation
  • MicroTransponder Inc.
  • Pain Management NYC
  • Curonix LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年植入式神经刺激设备市场：提供新机会的国家
  • 2029年植入式神经刺激设备市场：细分市场带来新机会
  • 2029年植入式神经刺激设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31973u

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $5.02 billion in 2024 to $5.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing demand for non-pharmacological treatments, growing demand for minimally invasive procedures, growing geriatric population, increasing the wide range of psychiatric disorders, and increasing incidence of chronic diseases.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $8.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to rising prevalence of neurological disorders, rise in prevalence of lifestyle diseases, rising awareness, increase in spinal cord injuries, and increasing healthcare expenditure. Major trends in the forecast period include sensing technology, increasing advances in neurostimulation technologies, technologically advanced products, incorporating closed-loop systems, and integrating wireless technology.

The forecast of 12.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on directional lead arrays and rechargeable power units, sourced from key regions such as Austria and Denmark, which could lead to reduced treatment options for movement disorders and higher costs for neuromodulation therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the implantable neurostimulation device market in the future. Neurological disorders are conditions that impact the structure or function of the nervous system, leading to a range of symptoms such as paralysis, seizures, and cognitive impairments. Factors such as high blood pressure, developmental abnormalities, and trauma or injury contribute to higher detection rates of these disorders. Implantable neurostimulation devices are utilized to modulate nerve activity and alleviate symptoms when other treatments prove ineffective or insufficient. For example, in 2024, the Alzheimer's Association, a US-based non-profit organization, reported that approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with 73% being 75 years or older. This figure is projected to increase to 12.7 million by 2050. Consequently, the rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market.

Key players in the implantable neurostimulation devices market are developing advanced technologies, such as spinal cord stimulation (SCS) systems, to address chronic pain conditions. An SCS system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord, providing pain relief and improving patient quality of life when other treatments fail. For instance, in December 2022, Abbott, a U.S.-based medical device company, received FDA approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the smallest rechargeable implantable spinal cord stimulator on the market, designed for maximum comfort. It features Abbott's BurstDR stimulation technology, which replicates natural brain firing patterns for enhanced pain relief and is preferred by 87% of patients over traditional tingling stimulation. Eterna requires as few as five recharges annually due to Xtend energy technology and supports full-body MRI scans with TotalScan technology. It is also adaptable to future advancements without replacement. Abbott's mobile app integration allows real-time tracking of battery life and charging status on iPhone devices.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition gives Amber access to valuable hardware, expertise, and manufacturing experience, accelerating the development and commercialization of Amber-UI. Bioinduction is a UK-based manufacturer specializing in implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

North America was the largest region in the implantable neurostimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices; Non-Rechargeable SCS Devices
  • 2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators; Adjustable Gastric Stimulators
  • 3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders; DBS Devices for Psychiatric Disorders
  • 4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence; SNS Devices for Fecal Incontinence
  • 5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy; VNS Devices for Depression
  • 6) By Other Types: Peripheral Nerve Stimulation (PNS); Cortical Stimulation Devices; Novel Neurostimulation Technologies
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Dignity Health; St. Jude Medical LLC; LivaNova PLC; Nevro Corp.; Axonics Inc.; NeuroPace Inc.; Bioness Inc.; Saluda Medical Pty Ltd.; SceneRay Co. Ltd.; NeuroMetrix Inc.; CURE Epilepsy; Synapse Biomedical Inc.; NeuroSigma Inc.; Nuvectra Corporation; MicroTransponder Inc.; Pain Management NYC; Curonix LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Neurostimulation Devices Market Characteristics

3. Implantable Neurostimulation Devices Market Trends And Strategies

4. Implantable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Neurostimulation Devices Market Growth Rate Analysis
  • 5.4. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Neurostimulation Devices Total Addressable Market (TAM)

6. Implantable Neurostimulation Devices Market Segmentation

  • 6.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Types
  • 6.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Parkinson's Disease
  • Urinary And Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Other Applications
  • 6.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • 6.4. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulation (SCS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rechargeable SCS Devices
  • Non-Rechargeable SCS Devices
  • 6.5. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Gastric Electric Stimulation (GES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Gastric Stimulators
  • Adjustable Gastric Stimulators
  • 6.6. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulation (DBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DBS Devices for Movement Disorders
  • DBS Devices for Psychiatric Disorders
  • 6.7. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulation (SNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • SNS Devices for Urinary Incontinence
  • SNS Devices for Fecal Incontinence
  • 6.8. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulation (VNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • VNS Devices for Epilepsy
  • VNS Devices for Depression
  • 6.9. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Nerve Stimulation (PNS)
  • Cortical Stimulation Devices
  • Novel Neurostimulation Technologies

7. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Neurostimulation Devices Market

  • 8.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Neurostimulation Devices Market

  • 9.1. China Implantable Neurostimulation Devices Market Overview
  • 9.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Neurostimulation Devices Market

  • 10.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Neurostimulation Devices Market

  • 11.1. Japan Implantable Neurostimulation Devices Market Overview
  • 11.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Neurostimulation Devices Market

  • 12.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Neurostimulation Devices Market

  • 13.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Neurostimulation Devices Market

  • 14.1. South Korea Implantable Neurostimulation Devices Market Overview
  • 14.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Neurostimulation Devices Market

  • 15.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • 15.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Neurostimulation Devices Market

  • 16.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Neurostimulation Devices Market

  • 17.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Neurostimulation Devices Market

  • 18.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Neurostimulation Devices Market

  • 19.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Neurostimulation Devices Market

  • 20.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Neurostimulation Devices Market

  • 21.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • 21.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Neurostimulation Devices Market

  • 22.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Neurostimulation Devices Market

  • 23.1. North America Implantable Neurostimulation Devices Market Overview
  • 23.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Neurostimulation Devices Market

  • 24.1. USA Implantable Neurostimulation Devices Market Overview
  • 24.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Neurostimulation Devices Market

  • 25.1. Canada Implantable Neurostimulation Devices Market Overview
  • 25.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Neurostimulation Devices Market

  • 26.1. South America Implantable Neurostimulation Devices Market Overview
  • 26.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Neurostimulation Devices Market

  • 27.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Neurostimulation Devices Market

  • 28.1. Middle East Implantable Neurostimulation Devices Market Overview
  • 28.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Neurostimulation Devices Market

  • 29.1. Africa Implantable Neurostimulation Devices Market Overview
  • 29.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Neurostimulation Devices Market Competitive Landscape
  • 30.2. Implantable Neurostimulation Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Nevro Corp.
  • 31.3. Axonics Inc.
  • 31.4. NeuroPace Inc.
  • 31.5. Bioness Inc.
  • 31.6. Saluda Medical Pty Ltd.
  • 31.7. SceneRay Co. Ltd.
  • 31.8. NeuroMetrix Inc.
  • 31.9. CURE Epilepsy
  • 31.10. Synapse Biomedical Inc.
  • 31.11. NeuroSigma Inc.
  • 31.12. Nuvectra Corporation
  • 31.13. MicroTransponder Inc.
  • 31.14. Pain Management NYC
  • 31.15. Curonix LLC

32. Global Implantable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

34. Recent Developments In The Implantable Neurostimulation Devices Market

35. Implantable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Neurostimulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Neurostimulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Neurostimulation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer